Swati S. More

1.8k total citations
44 papers, 1.3k citations indexed

About

Swati S. More is a scholar working on Physiology, Molecular Biology and Biochemistry. According to data from OpenAlex, Swati S. More has authored 44 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 12 papers in Molecular Biology and 10 papers in Biochemistry. Recurrent topics in Swati S. More's work include Alzheimer's disease research and treatments (11 papers), Sulfur Compounds in Biology (7 papers) and Advanced Glycation End Products research (7 papers). Swati S. More is often cited by papers focused on Alzheimer's disease research and treatments (11 papers), Sulfur Compounds in Biology (7 papers) and Advanced Glycation End Products research (7 papers). Swati S. More collaborates with scholars based in United States, Netherlands and Germany. Swati S. More's co-authors include Robert Vince, Kathleen M. Giacomini, James M. Beach, Ethan G. Geier, Wei Xie, Omar Akil, Sook Wah Yee, Ligong Chen, Lawrence R. Lustig and Alexandra G. Ianculescu and has published in prestigious journals such as Science, Journal of Neuroscience and Molecular Cell.

In The Last Decade

Swati S. More

40 papers receiving 1.3k citations

Peers

Countries citing papers authored by Swati S. More

Since Specialization

Citations

This map shows the geographic impact of Swati S. More's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Swati S. More with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Swati S. More more than expected).

Fields of papers citing papers by Swati S. More

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Swati S. More. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Swati S. More. The network helps show where Swati S. More may publish in the future.

Co-authorship network of co-authors of Swati S. More

This figure shows the co-authorship network connecting the top 25 collaborators of Swati S. More. A scholar is included among the top collaborators of Swati S. More based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Swati S. More. Swati S. More is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Oral Prodrug of a Novel Glutathione Surrogate Reverses Metabolic Dysregulation and Attenuates Neurodegenerative Process in Transgenic Alzheimer’s Mice 2025 ·ACS Pharmacology & Translational Science ·Swetha Pavani Rao, (unknown), Wei Xie, (unknown), (unknown), (unknown), (unknown), Ying Zhang, Robert Vince, Michael K. Lee, Swati S. More	0
2	Loss of the vitamin A receptor RBPR2 in mice disrupts whole‐body retinoid homeostasis and the quantitative balance regulating retinylidene protein synthesis 2025 ·The FASEB Journal ·Rakesh Radhakrishnan, (unknown), (unknown), Swati S. More, Glenn P. Lobo	1
3	Deletion of Glyoxalase 1 Exacerbates Acetaminophen-Induced Hepatotoxicity in Mice 2024 ·Antioxidants ·(unknown), Wei Xie, Swetha Pavani Rao, Jiashu Xie, Davis Seelig, Robert Vince, Michael K. Lee, Swati S. More	4
4	The full spectrum of SLC22 OCT1 mutations illuminates the bridge between drug transporter biophysics and pharmacogenomics 2024 ·Molecular Cell ·Sook Wah Yee, Christian B. Macdonald, (unknown), (unknown), (unknown), Jia Yang, (unknown), (unknown), Donovan Trinidad, Swati S. More, Linda Kachuri, John S. Witte, Lucie Delemotte, Kathleen M. Giacomini, Willow Coyote‐Maestas	17
5	Hyperspectral analysis of amyloid beta (Aβ) evolutional changes in preclinical to late‐stage Alzheimer’s disease using matched brain and retinal tissue 2023 ·Alzheimer s & Dementia ·Margaret E. Flanagan, (unknown), Carlos Zamudio, (unknown), (unknown), (unknown), (unknown), Kaouther Ajroud, Wei Xie, Catherine Bornbaum, (unknown), Swati S. More	0
6	Role of 3-Mercaptopyruvate Sulfurtransferase (3-MST) in Physiology and Disease 2023 ·Antioxidants ·Swetha Pavani Rao, (unknown), (unknown), Swati S. More	32
7	Angiotensin-converting enzyme gates brain circuit–specific plasticity via an endogenous opioid 2022 ·Science ·Brian H. Trieu, (unknown), (unknown), Dieter D. Brandner, (unknown), Adrina Kocharian, Cassandra L. Retzlaff, (unknown), (unknown), (unknown), Wei Xie, Ying Zhang, Swati S. More, Patrick E. Rothwell	33
8	Sulfanegen stimulates 3-mercaptopyruvate sulfurtransferase activity and ameliorates Alzheimer's disease pathology and oxidative stress in vivo 2022 ·Redox Biology ·Swetha Pavani Rao, Wei Xie, (unknown), (unknown), Jiashu Xie, (unknown), Robert Vince, Michael K. Lee, Swati S. More	19
9	LC-MS/MS determination of guanabenz E/Z isomers and its application to in vitro and in vivo DMPK profiling studies 2021 ·Journal of Pharmaceutical and Biomedical Analysis ·Jiashu Xie, Rongrong Jiang, Wei Xie, Bin Cao, Swati S. More	6
10	Topical Review: Studies of Ocular Function and Disease Using Hyperspectral Imaging 2021 ·Optometry and Vision Science ·(unknown), (unknown), (unknown), Robert Vince, Swati S. More	2
11	Sulfur-containing therapeutics in the treatment of Alzheimer’s disease 2021 ·Medicinal Chemistry Research ·Haizhou Zhu, (unknown), Wei Xie, Swati S. More	34
12	Hemolytic and antimalarial effects of tight-binding glyoxalase 1 inhibitors on the host-parasite unit of erythrocytes infected with Plasmodium falciparum 2016 ·Redox Biology ·(unknown), (unknown), Robert Vince, Swati S. More, Marcel Deponte	5
13	Tight‐binding inhibitors efficiently inactivate both reaction centers of monomeric Plasmodium falciparum glyoxalase 1 2012 ·FEBS Journal ·(unknown), Swati S. More, (unknown), Robert Vince, Marcel Deponte	20
14	Vorinostat Increases Expression of Functional Norepinephrine Transporter in Neuroblastoma In Vitro and In Vivo Model Systems 2011 ·Clinical Cancer Research ·Swati S. More, Melissa Itsara, Xiao-Dong Yang, Ethan G. Geier, (unknown), Youngho Seo, Henry F. VanBrocklin, William A. Weiss, Sabine Mueller, Daphne A. Haas‐Kogan, Steven G. DuBois, Katherine K. Matthay, Kathleen M. Giacomini	51
15	Organic Cation Transporters Modulate the Uptake and Cytotoxicity of Picoplatin, a Third-Generation Platinum Analogue 2010 ·Molecular Cancer Therapeutics ·Swati S. More, Shuanglian Li, Sook Wah Yee, Ligong Chen, Zhidong Xu, David M. Jablons, Kathleen M. Giacomini	61
16	Role of the Copper Transporter, CTR1, in Platinum-Induced Ototoxicity 2010 ·Journal of Neuroscience ·Swati S. More, Omar Akil, Alexandra G. Ianculescu, Ethan G. Geier, Lawrence R. Lustig, Kathleen M. Giacomini	140
17	Role of Organic Cation Transporter 1, OCT1 in the Pharmacokinetics and Toxicity of cis-Diammine(pyridine)chloroplatinum(II) and Oxaliplatin in Mice 2010 ·Pharmaceutical Research ·Shuanglian Li, Ying Chen, Shuzhong Zhang, Swati S. More, Xiaozhu Huang, Kathleen M. Giacomini	37
18	Organic Anion Transporter 2 (SLC22A7) Is a Facilitative Transporter of cGMP 2008 ·Molecular Pharmacology ·Cheryl D. Cropp, Takafumi Komori, James E. Shima, Thomas Urban, Sook Wah Yee, Swati S. More, Kathleen M. Giacomini	92
19	A metabolically stable tight-binding transition-state inhibitor of glyoxalase-I 2006 ·Bioorganic & Medicinal Chemistry Letters ·Swati S. More, Robert Vince	20
20	Design, synthesis, and binding studies of bidentate Zn-chelating peptidic inhibitors of glyoxalase-I 2006 ·Bioorganic & Medicinal Chemistry Letters ·Swati S. More, Robert Vince	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact